Summary
COR Chart
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap
Cencora delivered strong quarterly results and guidance upgrades, but expectations need to be moderated as these results should fade in the coming quarters. The valuation remains elevated at 17.9x forward P/E, well above the 5-year average, making the risk/reward unattractive at current levels. Key risks include heavy revenue exposure to Walgreens Boots Alliance, which faces solvency issues and plans to sell its COR stake.
3 Reasons Growth Investors Will Love Cencora (COR)
Cencora (COR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy
I initiate Cencora, Inc. with a Buy rating and a fair value of $337, due to its stable business model and strategic specialty drug expansion. Cencora's acquisition of Retina Consultants of America and focus on GLP-1 drugs strengthen its specialty solutions, supporting long-term growth and margin improvement. Management's commitment to digital infrastructure and specialty expertise positions Cencora to benefit from robust U.S. pharmaceutical sales growth and healthcare trends.
Cencora Inc. Dividends
 COR In 2 days Announced | Quarterly | $0.55 Per Share |
| COR 2 months ago Paid | Quarterly | $0.55 Per Share |
| COR 5 months ago Paid | Quarterly | $0.55 Per Share |
| COR 8 months ago Paid | Quarterly | $0.55 Per Share |
| COR 9 Aug 2024 Paid | Quarterly | $0.51 Per Share |
Cencora Inc. Earnings
| 12 Nov 2025 (In 3 months) Date | | 3.81 Cons. EPS | - EPS |
| 5 Nov 2025 (In 2 months) Date | | 3.85 Cons. EPS | - EPS |
| 4 Nov 2025 (In 2 months) Date | | 3.83 Cons. EPS | - EPS |
| 6 Aug 2025 Date | | 3.84 Cons. EPS | 4 EPS |
| 29 Jul 2025 Date | | - Cons. EPS | - EPS |
| COR In 2 days Announced | Quarterly | $0.55 Per Share |
| COR 2 months ago Paid | Quarterly | $0.55 Per Share |
| COR 5 months ago Paid | Quarterly | $0.55 Per Share |
| COR 8 months ago Paid | Quarterly | $0.55 Per Share |
| COR 9 Aug 2024 Paid | Quarterly | $0.51 Per Share |
| 12 Nov 2025 (In 3 months) Date | | 3.81 Cons. EPS | - EPS |
| 5 Nov 2025 (In 2 months) Date | | 3.85 Cons. EPS | - EPS |
| 4 Nov 2025 (In 2 months) Date | | 3.83 Cons. EPS | - EPS |
| 6 Aug 2025 Date | | 3.84 Cons. EPS | 4 EPS |
| 29 Jul 2025 Date | | - Cons. EPS | - EPS |
Cencora Inc. (COR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Cencora Inc. ever had a stock split?
Cencora Inc. Profile
| Medical - Distribution Industry | Healthcare Sector | Robert P. Mauch PharmD CEO | NYSE Exchange | 03090BBJ8 Cusip |
| US Country | 42,000 Employees | 15 Aug 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Overview
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
Products and Services
U.S. Healthcare Solutions:
- Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
- Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
- Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
- Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
- Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
- Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.
International Healthcare Solutions:
- Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
- Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
- Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.
Contact Information
